Contribution of Nuclear Factor of Activated T Cells C1 to the Transcriptional Control of Immunoreceptor Osteoclast-Associated Receptor but Not Triggering Receptor Expressed by Myeloid Cells-2 During Osteoclastogenesis

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m505820200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Triggering Receptor Expressed on Myeloid Cells Receptor Family Modulators: A Patent Review

Expert Opinion on Therapeutic Patents
MedicineDrug DiscoveryPharmacology
2014English

Heterogeneous Expression of the Triggering Receptor Expressed on Myeloid Cells-2 on Adult Murine Microglia

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2002English

Soluble Triggering Receptor Expressed on Myeloid Cells 1 and the Diagnosis of Ventilator-Associated Pneumonia: Response

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Soluble Triggering Receptor Expressed on Myeloid Cells 1 in Lung Cancer

Scientific Reports
Multidisciplinary
2018English

The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Role of Triggering Receptor Expressed on Myeloid Cells 2 in Neuroinflammation and Neurodegeneration of the Central Nervous System

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2018English

Down Syndrome Critical Region-1 Is a Transcriptional Target of Nuclear Factor of Activated T Cells-C1 Within the Endocardium During Heart Development

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

TGF-β1 Upregulates the Expression of Triggering Receptor Expressed on Myeloid Cells 1 in Murine Lungs

Scientific Reports
Multidisciplinary
2016English

The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy